Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2083)	1/4/2008 3:53:43 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

NSTK Is also trying to find support at the $3.50 level. bigcharts.marketwatch.com The Nov30 L of $3.34 was below its March 2001 L of $3.88, but above its May 2001 L of $3.24 <g> bigcharts.marketwatch.com NSTK has 3 consecutive Qs of double digits lower revenues & higher losses. The EL for 2007 is around $2.10 vs. $1.72 in 2006 Back on Nov13, it announced that it was going to establish its subsidiary, MDRNA, as an independent company & was transferring its intellectual property related to RNAi into MDRNA, with the idea that MDRNA could obtain independent investments to fund its operations. On Nov 7 was when the stock tanked after PG's decision to terminate the development and commercialization agreement for PTH1-34 Nasal Spray. It seems that NSTK may get to test the $2.5 level.<g> Bernard